D.6 Accounting for Shares and Warrants Issued by a SPAC
The guidance in this section is based on the typical terms and
conditions that have been observed in practice. Since the specific terms can affect
the accounting, consultation with an entity’s accounting advisers is
recommended.
In its IPO, a SPAC typically issues units to third-party investors at $10 per unit.
Each unit generally contains both of the following:
-
One Class A ordinary share (a “Class A share”).
-
A fraction of a warrant to purchase one Class A share at an exercise price of $11.50 (a “public warrant”).
The sponsor and its affiliates generally receive Class B ordinary shares (“Class B
shares”) in return for forming the SPAC. They may also purchase warrants (“private
placement warrants”) to acquire Class A shares at an exercise price of $11.50 per
share. Alternatively, in lieu of the sponsor, a so-called anchor investor may
purchase private placement warrants. The private placement warrants are generally
purchased at $1 or $1.50 per warrant, and the proceeds received by the SPAC are used
to pay the underwriting fees incurred in conjunction with the SPAC’s IPO.
In addition, entities may enter into other arrangements upon the formation of a SPAC
or at a later date before the SPAC completes a merger. Such arrangements may include
the following:
-
Forward contracts that (1) obligate the SPAC to issue additional Class A shares to a counterparty at a fixed price and (2) are settled immediately before the SPAC completes a merger with a target.
-
Warrants on Class A shares or on Class B shares that are issued to the sponsor, its affiliates, or third parties in return for providing financing to the SPAC.
-
Classes of preferred stock issued to third-party investors, the sponsor, or the sponsor’s affiliates.
-
Class A shares or Class B shares (or warrants on such shares) that are issued to the SPAC’s employees or third-party service providers as compensation for services provided.
While the discussion in this publication does not specifically address these other
arrangements, the accounting analysis for some of these arrangements (e.g., the
forward contracts and warrants described in the first two bullet points) may be
similar to that for public warrants or private placement warrants, which are
discussed below. SPACs that issue preferred shares or enter into share-based payment
arrangements should consider other applicable GAAP to determine the appropriate
accounting, including the potential effect of those instruments on reported EPS. Any
shares or warrants issued as part of a share-based payment arrangement must be
accounted for in accordance with ASC 718.
D.6.1 Unit of Account
Although initially issued as a unit, the Class A shares and public warrants
become separately tradable shortly after the IPO. In addition, upon exercise,
the public warrants do not alter the terms of the Class A shares previously
issued. Therefore, the public warrants (1) are legally detachable and separately
exercisable from the Class A shares issued as part of the units and (2) meet the
definition of a freestanding financial instrument in ASC 480-10-20.
Since the Class A shares and public warrants constitute separate units of
account, the proceeds from the issuance of these units (net of any direct and
incremental offering costs paid to the investors1) must be allocated between the two components. The appropriate allocation
method depends on how the public warrants are classified:2
-
Public warrants classified as liabilities — The SPAC must use the with-and-without method to allocate the net proceeds among the Class A shares and public warrants. Under that method, a portion of the net proceeds from the issuance of the units that equals the issuance-date fair value of the public warrants must first be allocated to such warrants. The entity then allocates the remaining net proceeds to the Class A shares. The with-and-without allocation approach avoids the recognition of a “day 1” gain or loss in earnings on the public warrants that is not associated with a change in their fair value (i.e., an entity does not recognize a day 1 gain or loss for the public warrants, which are subsequently measured at fair value, with changes in fair value recognized in earnings).
-
Public warrants classified as equity instruments — The SPAC must use the relative fair value method to allocate the net proceeds among the Class A shares and public warrants. Under that method, the SPAC separately estimates the fair values of the Class A shares and public warrants and then allocates the net proceeds in proportion to those fair value amounts. Because SPACs that apply the relative fair value method are required to independently measure each instrument, entities must make more fair value estimates under this method than under the with-and-without method. The Class B shares and any private placement warrants issued by the SPAC also generally represent separate units of account. If the private placement warrants were purchased by the sponsor in contemplation of the formation of the SPAC, the entity should consider (1) the need to allocate the amount it paid for these warrants between the Class B shares and private placement warrants and (2) whether such warrants represent share-based payment awards to the sponsor. In the discussion of the classification of the private placement warrants below, it is assumed that the warrants are not share-based payment arrangements. In a manner consistent with the above discussion of Class A shares and public warrants, if the private placement warrants are classified as liabilities, the initial amount allocated to those warrants must equal their initial fair value.
To perform the allocations discussed above, entities must measure the fair value
of the instruments in accordance with ASC 820. Although public warrants and
private placement warrants are generally not “in-the-money” on the issuance date
and are often contingently exercisable, their fair value is nevertheless greater
than zero. When measuring fair value, the entity must take into account the
relatively high probability that the SPAC will successfully merge with a target
and the warrants will subsequently become exercisable and contain intrinsic
value. The issuance-date fair value of a public warrant or private placement
warrant is not zero because there is no intrinsic value on that date. All
warrants on equity shares have time value, which equals the fair value of the
warrant when it is not in-the-money.
For more information about allocating proceeds to multiple freestanding financial
instruments, see Section 3.4 of Deloitte’s Roadmap
Issuer’s Accounting for Debt.
For more information about fair value measurements, see Deloitte’s Roadmap
Fair Value Measurements and Disclosures
(Including the Fair Value Option).
D.6.2 Classification of Class A Shares
Class A shares issued by a SPAC are equity in legal form. Therefore, these shares
should only be classified as liabilities if they represent (1) mandatorily
redeemable financial instruments under ASC 480-10-25-4 or (2) unconditional
obligations to deliver a variable number of equity shares that are liabilities
under ASC 480-10-25-14. In practice, liability classification of the Class A
shares has not been required under this guidance.
Since a SPAC is an SEC registrant, it must apply the guidance in ASC
480-10-S99-3A on redeemable equity securities. Class A shares generally contain
the following redemption provisions:
-
If the SPAC does not consummate a business combination by a specified date after the IPO (e.g., two years after the IPO), the SPAC will be liquidated and the Class A shares will automatically be redeemed at approximately $10 per share.
-
If the SPAC does consummate a business combination, all holders of the Class A shares have the right to redeem their shares at approximately $10 per share immediately before the consummation (generally subject to the requirement that the SPAC maintain a minimum amount of net tangible assets [e.g., $5 million]).
Because it is certain that the Class A shares will be redeemed or become
redeemable and no exceptions in ASC 480-10-S99-3A apply, the shares (1) must be
classified within temporary equity in the SPAC’s financial statements and (2)
are subject to the subsequent-measurement guidance in ASC 480-10-S99-3A. An
entity must subsequently measure the shares at their redemption amount because,
as a result of the allocation of net proceeds to the public warrants, the
initial carrying amount of the Class A shares will be less than $10 per share.
In accordance with ASC 480-10-S99-3A(15), there are two alternative methods that
an entity can apply when subsequently measuring Class A shares:
-
Remeasure the Class A shares at their redemption amount (i.e., $10 per share) immediately as if the end of the first reporting period after the IPO was the redemption date.
-
Accrete changes in the difference between the initial carrying amount and the redemption amount from the IPO date to the redemption date. To apply this method, the SPAC must consider the date on which it expects a business combination to occur, rather than merely accreting to the automatic redemption date.
Because a SPAC has two classes of shares (i.e., Class A shares and Class B
shares), it must apply the EPS guidance in ASC 480-10-S99-3A, which requires
specific accounting for the measurement adjustments. That is, the SPAC must
apply the two-class method of calculating EPS while taking into account the
measurement adjustments under an assumption that they represent dividends to the
holders of the Class A shares. Generally, public warrants and private placement
warrants do not represent participating securities; therefore, the application
of the two-class method of calculating EPS is limited to the allocation of the
SPAC’s net income or loss between the Class A shares and Class B shares.
After the completion of a business combination with a target, the redemption
features on the Class A Shares generally lapse. Therefore, in the absence of
other redemption provisions, the classification of such shares in temporary
equity is no longer required. That is, provided that the Class A shares are
redeemable only on an ordinary liquidation of the SPAC after a business
combination, which is generally the case, they do not have to be classified in
temporary equity.
D.6.3 Classification of Class B Shares
The Class B shares issued by a SPAC are equity in legal form. SPACs should
consider whether these shares are within the scope of ASC 718 on the basis of
the specific terms of the shares as well as other relevant facts and
circumstances. The classification guidance in ASC 718 refers to the
classification guidance in ASC 480, but there are additional considerations
under ASC 718 that SPACs should take into account. The Class B shares should be
classified as liabilities if they represent (1) mandatorily redeemable financial
instruments under ASC 480-10-25-4 or (2) unconditional obligations to deliver a
variable number of equity shares that are liabilities under ASC 480-10-25-14. In
practice, liability classification of the Class B shares has not been
observed.
Class B shares are generally not redeemable by the holder, and a
holder is not entitled to any proceeds if the SPAC is liquidated because of a
failure to complete a business combination. That is, in the absence of a merger
of the SPAC with a target, the Class B shares will be worthless.3 Because there are no redemption provisions, entities are not required to
classify Class B shares in temporary equity under ASC 480-10-S99-3A.
D.6.4 Public Warrants
To determine the appropriate classification of the public
warrants, SPACs must first consider the liability classification guidance in ASC
480. ASC 480-10-25-8 states:
An entity shall classify as a liability (or an asset in some
circumstances) any financial instrument, other than an outstanding
share, that, at inception, has both of the following characteristics:
- It embodies an obligation to repurchase the issuer’s equity shares, or is indexed to such an obligation.
- It requires or may require the issuer to settle the obligation by transferring assets.
The evaluation of whether public warrants are liabilities under ASC 480-10-25-8
will generally depend on when the warrants become exercisable.
The public warrants may be exercised before a
merger with a target.
|
The public warrants are liabilities under ASC 480-10-25-8
because the Class A shares received upon exercise of the
warrants may be redeemed at the holder’s option upon a
merger of the SPAC. The SPAC is obligated to use its
best efforts to complete a merger.
|
The public warrants may be exercised only after a
merger with a target. For example, they may be exercised
only upon the later of (1) 30 days after the SPAC
completes a business combination or (2) 12 months from
the date on which the SPAC’s IPO closes.
|
The public warrants are not liabilities under ASC
480-10-25-8 because, once the warrants are exercisable,
the holder will receive Class A shares that are not
redeemable. As discussed above, once a merger with a
target is completed, the holders of Class A shares can
no longer redeem their shares. Rather, such shares are
redeemable only upon an ordinary liquidation of the
combined company.
|
If the public warrants are not liabilities under ASC 480-10-25-8, the SPAC should
consider whether they represent liabilities under ASC 480-10-25-14. In practice,
it would be unusual for such warrants to represent an obligation to issue a
variable number of equity shares whose monetary value is based solely or
predominantly on (1) a fixed amount, (2) variations in something other than the
fair value of the Class A shares, or (3) variations that are inversely related
to the fair value of the Class A shares. Public warrants that are not
liabilities under ASC 480 are classified as liabilities or equity in accordance
with ASC 815-40.4
To be classified as an equity instrument under ASC 815-40, the public warrants
must meet two conditions:
-
They are indexed to the SPAC’s stock.
-
They meet the criteria for equity classification (i.e., the SPAC controls the ability to settle the warrants in shares; note that these criteria are relevant even if the contract requires settlement in shares).
D.6.4.1 Indexation
ASC 815-40-15 contains a two-step model that an entity must apply to
determine whether the public warrants are indexed to the SPAC’s stock. The
evaluation must consider the following:
-
Step 1 — The exercise or settlement of the contract (“contingent exercise provisions”).
-
Step 2 — The monetary value of the settlement amount (i.e., factors that affect the settlement amount, or “settlement provisions”).
For each unit of account, the entity evaluates the indexation requirements in
ASC 815-40-15. If the entity determines that the contract is not considered
indexed to the company’s stock, the contract must be classified as a
liability (i.e., equity classification is never permitted).
ASC 815-40-15-7A addresses step 1 of the two-step indexation evaluation and
states, in part:
An exercise contingency shall not preclude an instrument
(or embedded feature) from being considered indexed to an entity’s own
stock provided that it is not based on either of the following:
- An observable market, other than the market for the issuer’s stock (if applicable)
- An observable index, other than an index calculated or measured solely by reference to the issuer’s own operations (for example, sales revenue of the issuer; earnings before interest, taxes, depreciation, and amortization of the issuer; net income of the issuer; or total equity of the issuer).
The following features, which are exercise contingencies that generally exist
in public warrants, would not preclude the warrants from being indexed to
the SPAC’s stock in step 1 under ASC 815-40-15:
-
The public warrants are exercisable only if the SPAC completes a business combination.
-
The public warrants are no longer exercisable if the SPAC is liquidated.
-
The SPAC can force early exercise of the public warrants by means of certain redemption features.
While the above features represent the typical contingent exercise provisions
in public warrants, there may be other features that must be evaluated in
step 1 under ASC 815-40-15.
ASC 815-40-15-7C through 15-7I discuss the evaluation of settlement
provisions. Any provision that (1) can potentially alter either the exercise
price or the number of Class A shares that are issuable upon exercise of the
public warrants and (2) is not considered a down-round provision must be
evaluated to determine whether it represents an input into the pricing of a
fixed-for-fixed forward or an option on equity shares. Common provisions
that must be evaluated include the following:
-
Antidilution-type adjustment provisions.
-
Replacement of the Class A shares with other consideration in a reorganization or recapitalization.
-
Adjustments to the exercise price or number of Class A shares as a result of the SPAC’s issuance of additional Class A shares or other equity instruments at a price or effective price that is less than the public warrants’ exercise price (note that for such a provision not to preclude the public warrants from being indexed to the SPAC’s stock, the provision must meet the ASC master glossary definition of a down-round feature).
-
Adjustments to the number of Class A shares issuable to compensate the holder for lost time value upon an early settlement of the public warrants.
-
Adjustments to the exercise price or number of Class A shares that are made at the discretion of the SPAC to benefit the holders of the public warrants.
Public warrants generally contain multiple provisions under which the
settlement amount is adjusted to compensate the holders for lost time value
upon an early exercise or settlement. For such provisions not to preclude
the public warrants from being considered indexed to the SPAC’s stock in
step 2 under ASC 815-40-15, the entity must conclude that the adjustment
(e.g., the increase in the number of additional Class A shares issuable)
represents a reasonable amount of compensation to the holder for lost time
value. We generally believe that if the additional value paid to the holder
does not exceed the amount of lost time value, the adjustment will not
preclude the public warrants from being indexed to the SPAC’s stock in step
2 under ASC 815-40-15. That is, as long as the holder would receive a
monetary amount upon settlement that is (1) not less than the intrinsic
value of the public warrants on the early settlement date and (2) not more
than the fair value of the public warrants on the early settlement date, the
settlement provision would not preclude the public warrants from being
indexed to the SPAC’s stock in step 2 under ASC 815-40-15. In this
determination, “fair value” means an amount that is consistent with the fair
value measurement guidance in ASC 820.
Many public warrants contain a provision that allows the
SPAC to call them for either (1) $0.10 per warrant or (2) Class A shares,
provided that the shares’ fair value equals or exceeds $10.5 If the SPAC exercises this call right, the holders are entitled to
exercise and settle the public warrants on a net-share basis. While such a
feature may specify the payment of $0.10 per warrant, the economic substance
of the feature is the same even if the $0.10 payment is not specified.
(Hereafter, such a call right is also referred to as a
“redemption-for-stock” feature.) The determination of the number of Class A
shares issuable upon a settlement of a redemption-for-stock feature is based
on a table whose axes are share price and time to maturity. The purpose of
the table is to prescribe the amount of compensation the holder should
receive for lost time value for any settlement that occurs when the Class A
share price is below $18. For the settlement amounts in this table not to
preclude the public warrants from being indexed to the SPAC’s stock in step
2 under ASC 815-40-15, the entity must conclude, on the basis of reasonable
assumptions as of the issuance date of the public warrants, that each
settlement number in the table represents a reasonable amount of
compensation for lost time value. The assumptions that affect the estimated
fair value of the public warrants should affect the number of shares
included in each cell in the settlement table and should be determined in a
commercially reasonable manner. Those assumptions include stock volatility,
interest rates, and dividends. Because these assumptions change over time, a
SPAC cannot conclude that a potential settlement based on share amounts in
the table does not preclude the public warrants from being indexed to the
SPAC’s stock in step 2 under ASC 815-40-15 solely because the share amounts
in the table are the same as those in other public warrant agreements issued
by other SPACs. Rather, each SPAC will generally need to consult with
valuation specialists to determine whether the settlement provisions that
apply in accordance with these settlement tables preclude the public
warrants from being indexed to the SPAC’s stock under step 2 of ASC
815-40-15. See Chapter
4 of Deloitte’s Roadmap Contracts on an Entity’s Own
Equity for more information about the indexation
requirements.
Some public warrants contain a provision
indicating that the settlement amount could differ if the warrants are held
by the SPAC’s officers or directors. This settlement difference would arise
if the SPAC exercises its redemption-for-stock feature. In such cases,
holders of public warrants that are not officers or directors of the SPAC
would receive a number of Class A shares per warrant on the basis of the
table described in the previous paragraph, but holders of public warrants
that are officers or directors of the SPAC would receive a number of Class A
shares on the basis of the fair value of their warrants. The following
example illustrates such a provision:
Example Provision
Public Warrants held by the
Company’s officers or directors. The Company
agrees that if Public Warrants are held by any of
the Company’s officers or directors, the Public
Warrants held by such officers and directors will be
subject to the redemption rights provided in Section
[X], except that such officers and directors shall
only receive “Fair Market Value” (“Fair Market
Value” in this Section [X.X] shall mean
the last sale price of the Public Warrants on the
Alternative Redemption Date) for such Public
Warrants so redeemed.
On April 12, 2021, the SEC staff issued Staff Statement on Accounting and Reporting Considerations for
Warrants Issued by Special Purpose Acquisition Companies
(“SPACs”) (the “SEC Staff Statement”), which
addresses certain balance sheet classification matters related to warrants
issued by SPACs. The SEC Staff Statement discusses a scenario related to the
terms of warrants that were issued by a SPAC and states, in part:
[T]he
warrants included provisions that provided for potential changes to the
settlement amounts dependent upon the characteristics of the holder of
the warrant. Because the holder of the instrument is not an input into
the pricing of a fixed-for-fixed option on equity shares, OCA staff
concluded that, in this fact pattern, such a provision would preclude
the warrants from being indexed to the entity’s stock, and thus the
warrants should be classified as a liability measured at fair value,
with changes in fair value each period reported in earnings.
ASC 815-40-15-7E discusses the inputs into the pricing of a fixed-for-fixed
option on equity shares. As indicated in the SEC Staff Statement, the holder
is not an input into the pricing of an option on equity shares. Therefore,
if the settlement terms of the instrument (i.e., the exercise price or
number of shares) could potentially vary on the basis of its holder, the
instrument is not considered indexed to the SPAC’s stock. Public warrants
with an officer or director provision such as the one described above have
settlement terms that depend on the holder. Accordingly, such public
warrants are not considered indexed to the SPAC’s stock and must be
classified as liabilities. Note that such liability classification is
required both before and after a SPAC merges with a target.
In addition, some public warrants contain a provision that caps the holder to
0.361 shares per warrant in some, but not all, circumstances. The holder of
such a warrant may avoid being subject to the cap if (1) it exercises the
warrant on a physical (cash) basis and (2) such exercise is allowed only if
there is an effective registration statement for the underlying shares. In
such circumstances, the warrant would be considered indexed to the condition
that there is an effective registration statement in a manner that is
inconsistent with ASC 815-40’s requirements for equity classification (i.e.,
the holder would potentially receive less value when the underlying shares
are not registered for resale). As a result, such public warrants would not
be considered indexed to the issuer’s shares under ASC 815-40-15 and must be
classified as liabilities.
D.6.4.2 Equity Classification Conditions
If an entity determines that the public warrants are considered indexed to
the SPAC’s stock under ASC 815-40, it must evaluate the conditions in ASC
815-40-25 to determine whether it controls the ability to settle the
contract in its shares. Only contracts for which the entity controls
settlement in shares (i.e., that meet the conditions in ASC 815-40-25) may
be classified in equity. For example, the public warrants would not meet the
equity classification requirements in ASC 815-40-25 if (1) the holder of
public warrants is able to net-cash-settle its warrants upon the occurrence
of an event outside the SPAC’s control and (2) holders of the common shares
underlying such warrants are not entitled to the same cash settlement
right.
Public warrants often
contain a provision that allows their holders to receive cash in the event
of a tender or exchange offer involving the common shares underlying such
warrants. (Note that private placement warrants may also be subject to this
provision; therefore, the discussion in this section applies to both public
warrants and private placement warrants.) An example of such a provision (a
tender offer provision) is as follows:6
Example Provision
(ii) [I]f a tender, exchange or redemption offer
shall have been made to and accepted by the holders
of the Common Stock (other than a tender, exchange
or redemption offer made by the Company in
connection with redemption rights held by
stockholders of the Company as provided for in the
Company’s amended and restated certificate of
incorporation or as a result of the repurchase of
shares of Common Stock by the Company if a proposed
initial Business Combination is presented to the
stockholders of the Company for approval) under
circumstances in which, upon completion of such
tender or exchange offer, the maker thereof,
together with members of any group (within the
meaning of Rule 13d-5(b)(1) under the Exchange Act
(or any successor rule)) of which such maker is a
part, and together with any affiliate or associate
of such maker (within the meaning of Rule 12b-2
under the Exchange Act (or any successor rule)) and
any members of any such group of which any such
affiliate or associate is a part, own beneficially
(within the meaning of Rule 13d-3 under the Exchange
Act (or any successor rule)) more than 50% of the
outstanding shares of Common Stock, the holder of a
Warrant shall be entitled to receive as the
Alternative Issuance, the highest amount of cash,
securities or other property to which such holder
would actually have been entitled as a stockholder
if such Warrant holder had exercised the Warrant
prior to the expiration of such tender or exchange
offer, accepted such offer and all of the Common
Stock held by such holder had been purchased
pursuant to such tender or exchange offer, subject
to adjustments (from and after the consummation of
such tender or exchange offer) as nearly equivalent
as possible to the [antidilution] adjustments.
The SEC Staff Statement addresses the effect of this type of provision on the
classification of public warrants and private placement warrants issued by a
SPAC. It states, in part:
GAAP further includes a general principle that if an
event that is not within the entity’s control could require net cash
settlement, then the contract should be classified as an asset or a
liability rather than as equity. However, GAAP provides an exception
to this general principle whereby equity classification would not be
precluded if net cash settlement can only be triggered in
circumstances in which the holders of the shares underlying the
contract also would receive cash. Scenarios where this exception
would apply include events that fundamentally change the ownership
or capitalization of an entity, such as a change in control of the
entity, or a nationalization of the entity.
We recently evaluated a fact pattern involving warrants issued by a
SPAC. The terms of those warrants included a provision that in the
event of a tender or exchange offer made to and accepted by holders
of more than 50% of the outstanding shares of a single class of
common stock, all holders of the warrants would be entitled to
receive cash for their warrants. In other words, in the event of a
qualifying cash tender offer (which could be outside the control of
the entity), all warrant holders would be entitled to cash, while
only certain of the holders of the underlying shares of common stock
would be entitled to cash. OCA staff concluded that, in this fact
pattern, the tender offer provision would require the warrants to be
classified as a liability measured at fair value, with changes in
fair value reported each period in earnings.
The evaluation of the accounting for contracts in an
entity’s own equity, such as warrants issued by a SPAC, requires
careful consideration of the specific facts and circumstances for
each entity and each contract. OCA is available for consultation on
accounting and financial reporting issues, including relating to an
entity’s specific fact pattern on issues similar to those described
above or on other instruments and accounting issues. [Footnotes
omitted]
The SEC Staff Statement addresses a scenario in which a SPAC and a target
merge, and after the transaction, the combined company has two classes of
common shares — Class A and Class B. The tender offer provision pertains to
the public warrants and private placement warrants, which are both
exercisable into Class A shares. The Class B shares control the entity and
would continue to have such control regardless of the number of Class A
shares involved in a tender or exchange offer (i.e., there would not be a
change in control of the entity). The SEC staff concluded that as a result
of the tender offer provision, the public warrants and private placement
warrants would not meet the ASC 815-40-25 conditions for equity
classification because (1) all such warrants could be cash settled upon an
event outside the entity’s control and it is possible that less than all or
substantially all of the Class A shares would be eligible to receive cash
(e.g., the tender offer provision applies if 50.1 percent of the Class A
shares are involved in a tender or exchange offer) and (2) the provision
that would result in such a cash settlement would not lead to a change in
control of the entity.
In reaching this conclusion, the SEC staff acknowledged that ASC 815-40-55-2
through 55-4 can be interpreted as providing a limited exception to the
general principle that an equity-linked holder cannot be entitled to receive
cash unless the holders of all shares underlying the contract are also
entitled to receive cash. The paragraphs that describe this limited
exception state:
55-2 An event that causes a change in control of an entity is
not within the entity’s control and, therefore, if a contract
requires net cash settlement upon a change in control, the contract
generally must be classified as an asset or a liability.
55-3 However, if a change-in-control provision requires that
the counterparty receive, or permits the counterparty to deliver
upon settlement, the same form of consideration (for example, cash,
debt, or other assets) as holders of the shares underlying the
contract, permanent equity classification would not be precluded as
a result of the change-in-control provision. In that circumstance,
if the holders of the shares underlying the contract were to receive
cash in the transaction causing the change in control, the
counterparty to the contract could also receive cash based on the
value of its position under the contract.
55-4 If, instead of cash, holders of the shares underlying the
contract receive other forms of consideration (for example, debt),
the counterparty also must receive debt (cash in an amount equal to
the fair value of the debt would not be considered the same form of
consideration as debt).
However, the SEC staff concluded that this exception could only be applied if
the event giving rise to the cash settlement of the equity-linked financial
instrument would always cause a change in control of the entity. Because a
change in control could never occur in the situation in the example, the SEC
staff concluded that the limited exception would not apply and, therefore,
that the registrant’s public warrants and private placement warrants would
not meet the equity classification conditions in ASC 815-40-25 (i.e., the
cash settlement associated with the tender offer provision violated the
general principle in ASC 815-40-25 for equity classification). As a result,
the registrant would be required to classify those warrants as
liabilities.
On the basis of informal discussions, we understand that the SEC staff’s
conclusion specifically addresses the particular facts and circumstances of
the registrant, which has a dual common-share structure. Therefore, the
warrant would not meet the equity classification conditions in ASC 815-40-25
and must be classified as a liability if (1) a public warrant or private
placement warrant contains a provision similar to the tender offer provision
described above and (2) the registrant has a dual common-share structure in
which holders of both classes are entitled to vote on matters submitted to
the vote of the entity’s stockholders (which is usually the case before any
acquisition of a target by the SPAC). The same conclusion would apply if
there was a single common-share structure but holders of other classes of
securities were entitled to currently vote on matters submitted to the vote
of the entity’s stockholders.
However, we do not believe that the SEC staff’s conclusion must be applied
when there is a similar tender offer provision if (1) there is only a single
class of voting common shares and (2) only holders of that class of shares
are entitled to vote on matters submitted to the entity’s stockholders
(i.e., the entity has no other class of voting securities). We believe that,
in these circumstances, it is acceptable to apply the limited exception for
changes in control in ASC 815-40-55-2 through 55-4.7
The table below provides
examples of tender offer provisions similar to the one described above and
explains when liability classification of public warrants and private
placement warrants is and is not required.
Liability Classification Is Required
|
Liability Classification Is Not Required
|
---|---|
Before a merger with a target, a SPAC has two classes
of voting shares (Class A and Class B). The tender
offer provision pertains only to the warrants on the
Class A shares.
Liability classification of such warrants is required
as a result of the tender offer provision because
(1) it is possible that the warrants will be cash
settled in a tender or exchange offer made by a
third party (even if those warrants are not
otherwise currently exercisable) and (2) such a
tender or exchange offer may not result in a change
in control of the SPAC.
|
After a merger with a SPAC, the combined company has
a single class of common shares that controls the
entity. The tender offer provision pertains only to
the warrants on this single class of shares. The
entity has no other voting securities.
Liability classification of such warrants is not
required as a result of the tender offer provision
because, in any cash settlement of the warrants, the
group of common shareholders before the tender or
exchange offer will no longer control the entity
after the tender or exchange offer (i.e., a third
party or group obtains control of the entity).
|
After a merger with a SPAC, the combined company has
a single class of common shares. Although the common
shareholders collectively control the entity, there
are outstanding preferred shares that are entitled
to currently vote on an as-converted basis.
Liability classification of such warrants is required
as a result of the tender offer provision because
(1) it is possible that the warrants will be cash
settled in a tender or exchange offer made by a
third party and (2) such a tender or exchange offer
may not result in a change in control of the
entity.
|
After a merger with a SPAC, the combined company has
two classes of shares (Class A and Class B). The
Class A shares have voting rights and control the
entity; the Class B shares have no voting rights.
The entity has no other securities with voting
rights. The tender offer provision pertains only to
the warrants on the Class A shares.
Although there is a dual-class common-share
structure, liability classification of such warrants
is not required as a result of the tender offer
provision. This is because, in any cash settlement
of the warrants, the group of common shareholders
before the tender or exchange offer will no longer
control the entity after the tender or exchange
offer (i.e., a third party or group obtains control
of the entity).
|
The above table only addresses certain scenarios. Consultation with an
entity’s independent advisers is recommended if (1) unique facts and
circumstances are associated with the terms of the tender offer provision or
the entity’s capital structure or (2) contracts other than equity shares
convey control to their holder.
See Chapter 5 of Deloitte’s Roadmap
Contracts on an Entity’s Own
Equity for more information about the equity
classification conditions in ASC 815-40-25.
Connecting the Dots
On the basis of the SEC Staff Statement, a
registrant may conclude that its historical accounting for warrants
was incorrect (e.g., equity classification when terms consistent
with the SEC Staff Statement require liability classification). In
such situations, the registrant must evaluate the materiality of the
error to the previously filed financial statements in accordance
with the guidance in SAB Topic
1.M. For more information about assessing materiality
and SEC comments on this topic, see Section 2.15 of Deloitte’s
Roadmap SEC
Comment Letter Considerations, Including Industry
Insights.
If a registrant concludes that the error was
material to previously issued financial statements, it must disclose
the error by filing Form 8-K, Item 4.02, within four business days
of determining that the previously issued financial statements and
related audits and reviews should not be relied upon. The registrant
also must amend its most recently filed Form 10-K and any
subsequently filed Forms 10-Q to restate (1) the financial
statements, including applicable disclosures required for error
corrections (i.e., ASC 250-50); (2) MD&A; (3) CAEs that are
related to the warrants; (4) quarterly financial information for
interim periods during the fiscal periods that were affected by the
error (in accordance with Regulation S-K, Item 302); and (5) any
other information in the filings that was affected by the change
(e.g., risk factors, the business section). If the registrant’s
auditor communicated CAMs in its auditor’s report (see Section
D.3.1.4), it needs to reevaluate CAMs in light of
restatements related to the warrant matter and determine whether it
needs to make a change in an existing CAM or identify a new CAM.
The registrant should also consider whether the factors that led to
the restatement represent a material weakness in ICFR or ineffective
DCPs. The SEC staff often comments when companies conclude that
either ICFR or DCPs remained effective after a material restatement.
For more information, see Sections 3.5 and
3.6 of Deloitte’s Roadmap SEC Comment Letter Considerations, Including
Industry Insights.
If the registrant concludes that the error was either (1) not
material to the prior period being changed but would be material to
the current period if corrected in the current period or (2) not
material to any periods being presented in the required financial
statements and disclosures, it may update the prior periods in
future filings. In addition, as noted in the SEC Staff Statement,
registrants that determine that the errors are not material to the
required financial statements and disclosures included in a pending
transaction may provide the staff, via EDGAR correspondence, with a
written representation to that effect. A registrant must also
evaluate the impact of an immaterial misstatement on ICFR and DCPs
since the severity of a deficiency in ICFR depends on whether it is
reasonably possible that the deficiency could have resulted in a
material misstatement. For more information, see Section
3.6.2 of Deloitte’s Roadmap SEC Comment Letter Considerations, Including
Industry Insights.
D.6.4.3 Earnings per Share
Because public warrants represent potential common shares, an entity must
apply ASC 260 in accounting for and disclosing such warrants. In calculating
diluted EPS, the SPAC should consider the guidance on contingently issuable
shares.
In addition, regardless of whether they are classified as equity or liability
instruments, public warrants that give the holders nonforfeitable rights to
dividends represent participating securities regardless of whether the SPAC
actually declares or pays dividends.
See Deloitte’s Roadmap Earnings per
Share for more information about contingently issuable
shares and participating securities.
D.6.5 Private Placement Warrants
Although the terms of private placement warrants are often
similar to the terms of public warrants, there may be key differences, such as
the following:
-
Public warrants often have a redemption-for-stock feature or a feature that allows the SPAC to call such warrants for $0.01 in the event that the holder does not exercise them. Private placement warrants do not contain redemption features that allow the SPAC to call the warrants to force early exercise.
-
Some exercise price adjustments are calculated differently for private placement warrants than they are for public warrants.
-
The cashless (net share) settlement formulas for private placement warrants differ from those for public warrants.
The terms of private placement warrants generally change if they are transferred
to a nonpermitted transferee (e.g., a party other than the sponsor or its
affiliates). In such situations, the private placement warrants become public
warrants.
D.6.5.1 Indexation
As noted in the discussion of the indexation of public
warrants (see Section
D.6.4.1), ASC 815-40-15 contains a two-step model that an entity
must apply to determine whether private placement warrants are indexed to
the SPAC’s stock. Under this model, in addition to evaluating contingent
exercise provisions, an entity must determine whether any potential
adjustment to the exercise price or settlement amount represents an input
into the pricing of a fixed-for-fixed option on equity shares. ASC
815-40-15-7E discusses such inputs.
As indicated in the SEC Staff Statement, the holder is not an input into the
pricing of an option on equity shares. Therefore, a private placement
warrant that contains any of the provisions below is considered not indexed
to the SPAC’s stock and must be classified as a liability because the
provision either (1) ceases to apply or (2) is applied differently if the
private placement warrants are transferred to a nonpermitted transferee and
thus become public warrants. That is, in these cases, the settlement amount
(i.e., exercise price or number of shares) of the private placement warrants
depends on the holder. Note that the provisions below only affect the
classification of private placement warrants because public warrants cannot
become private placement warrants.
-
Redemption-for-stock feature — Public warrants may contain a provision that allows the SPAC to call them for either (1) $0.10 per warrant or (2) Class A shares, provided that the shares’ fair value equals or exceeds $10. When the SPAC exercises this call right, the holders are entitled to exercise and settle the public warrants on a net-share basis. While such a feature may specify the payment of $0.10 per warrant, the economic substance of the feature is the same even if the $0.10 payment is not specified. An example of a redemption-for-stock feature is as follows:Example ProvisionRedemption of warrants for common stock. Subject to Sections [X] and [Y] hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, ninety (90) days after they are first exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in Section [Z] below, at a price equal to a number of shares of Common Stock determined by reference to the table below, based on the redemption date (calculated for purposes of the table as the period to expiration of the Warrants) and the “Fair Market Value” (as such term is defined in subsection [W](b)) (the “Alternative Redemption Price”), provided that the last sales price of the Common Stock reported has been at least $10.00 per share (subject to adjustment in compliance with Section [V] hereof), on the trading day prior to the date on which notice of the redemption is given and provided that there is an effective registration statement covering the Common Stock issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section [Z] below) or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection [W].The exact Fair Market Value and Redemption Date (as defined below) may not be set forth in the table above, in which case, if the Fair Market Value is between two values in the table or the Redemption Date is between two redemption dates in the table, the number of Common Stock to be issued for each Warrant redeemed will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower Fair Market Values and the earlier and later redemption dates, as applicable, based on a 365- or 366-day year, as applicable.The stock prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable upon exercise of a Warrant is adjusted pursuant to Section V. The adjusted stock prices in the column headings shall equal the stock prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a Warrant as so adjusted. The number of shares in the table above shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a Warrant.
-
Exercise price adjustment upon certain changes of control — Many warrants issued by a SPAC contain a provision that requires adjustment of the exercise price if (1) there is a change of control of the entity and (2) less than 70 percent of the consideration received is stock listed on an exchange. The calculation of the exercise price adjustment for public warrants differs from that for private placement warrants. That is, for public warrants, the adjustment is calculated on the basis of a capped American call option; however, for private placement warrants, the adjustment is calculated on the basis of an uncapped American call option.8 If, however, the private placement warrants are transferred to a nonpermitted transferee, the exercise price adjustment changes from being calculated on the basis of an uncapped American call option to being calculated on the basis of a capped American call option. An example of such a provision is shown below.Example Provision[I]f less than 70% of the consideration receivable by the holders of the Common Stock in the applicable event is payable in the form of common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section [X] of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event, (3) the assumed volatility shall be the 90 day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change in shares of Common Stock covered by subsection [X.1.1], then such adjustment shall be made pursuant to subsection [X.1.1] or Sections [X.2, X.3] and this Section [X.4]. The provisions of this Section [X.4] shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant.
-
Different formulas used to determine the number of shares delivered in a cashless (net share) settlement — There are often multiple definitions of “fair market value” that may apply in the event of a cashless settlement. If the definition(s) applicable to public warrants differ from the definition(s) applicable to private placement warrants in any respect, the private placement warrants are not considered indexed to the SPAC’s stock because the applicable definitions change if the private placement warrants are transferred to a nonpermitted transferee and thus become public warrants. Two examples of a potential difference are as follows:
-
For public warrants:Example Provision[T]he volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary.
-
For private placement warrants:Example Provision[T]he average last sale price of the Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which notice of exercise of the Warrant is sent to the Warrant Agent.
-
For public warrants in the case of notice of redemption at $0.01:Example ProvisionThe average reported last sale price of the shares of Common Stock for the ten trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrant.
-
For private placement warrants:Example Provision[T]he average reported last sale price of the shares of Common Stock for the ten trading days ending on the third trading day prior to the date of exercise.
-
If a private placement warrant (1) does not contain any settlement provision
(i.e., a provision other than a standard antidilution adjustment that
affects the exercise price or number of shares) or (2) could never become a
public warrant, the private placement warrant could be classified as equity
provided that no other provisions or circumstances cause the warrant not to
be considered indexed to the SPAC’s stock or not to meet the equity
classification conditions in ASC 815-40-25. As discussed above, as a result
of a tender offer provision, private placement warrants may not meet the
equity classification conditions in ASC 815-40-25.
In current practice, because warrant agreements generally
have one or more of the provisions above, most private placement warrants
are not considered indexed to the SPAC’s stock and must be classified as a
liability both before and after a merger of the SPAC with a target.9 On the basis of the SEC Staff Statement, some registrants may need to
determine whether they have classified such warrants incorrectly in
previously filed financial statements. For information about evaluating
errors, see the Connecting the
Dots above.
D.6.6 Accounting for Issuance Costs
Nonauthoritative AICPA Guidance
Technical Q&As Section 4110, “Issuance of Capital
Stock”
.01 Expenses Incurred in Public Sale of Capital
Stock
Inquiry — A closely held corporation is issuing
stock for the first time to the public.
How would costs, such as legal and accounting fees,
incurred as a result of this issue, be handled in the
accounting records?
Reply — Direct costs of obtaining capital by
issuing stock should be deducted from the related
proceeds, and the net amount recorded as contributed
stockholders’ equity. Assuming no legal prohibitions,
issue costs should be deducted from capital stock or
capital in excess of par or stated value.
Such costs should be limited to the direct cost of
issuing the security. Thus, there should be no
allocation of officers’ salaries, and care should be
taken that legal and accounting fees do not include any
fees that would have been incurred in the absence of
such issuance.
SEC Staff Accounting Bulletins
SAB Topic 5.A, Expenses of Offering [Reproduced in ASC
340-10-S99-1]
Facts: Prior to the effective date of an offering
of equity securities, Company Y incurs certain expenses
related to the offering.
Question: Should such costs be deferred?
Interpretive Response: Specific incremental costs
directly attributable to a proposed or actual offering
of securities may properly be deferred and charged
against the gross proceeds of the offering. However,
management salaries or other general and administrative
expenses may not be allocated as costs of the offering
and deferred costs of an aborted offering may not be
deferred and charged against proceeds of a subsequent
offering. A short postponement (up to 90 days) does not
represent an aborted offering.
D.6.6.1 Issuance Costs Incurred in Conjunction With a SPAC’s IPO
In addition to the above guidance, SAB Topic 2.A.6
states, in part, that “[f]ees paid to an investment banker in connection
with a business combination or asset acquisition, when the investment banker
is also providing interim financing or underwriting services, must be
allocated between acquisition related services and debt issue costs.”
In accordance with this guidance, a SPAC should evaluate which fees and costs
incurred in conjunction with its IPO, as well as with any issuance of
private placement warrants or other securities, represent direct and
incremental costs that would be eligible for deferral. For example,
underwriting costs incurred to issue the units, as well as certain legal and
accounting fees, may be direct and incremental costs. However, costs that
are not direct or incremental must be expensed as incurred.
After identifying the group of eligible costs that would qualify for
deferral, the SPAC should appropriately allocate such costs to the various
instruments issued. For example, when a SPAC incurs underwriting costs with
an investment bank (including deferred costs) and the amount of those costs
is directly related to the proceeds received from issuing the units, those
costs should only be allocated to the units. Other costs that are not
directly related to a specific type of instrument may be allocated by using
a rational basis.
The underwriting fees are generally allocated only to the units because the
amount of such costs is directly related to the number of units issued.
Since the units contain two separate units of account (i.e., Class A shares
and public warrants), such costs will be further allocated to those separate
units of account. Any amounts allocated to Class A shares would be
classified in temporary equity because those shares are redeemable
securities. Any costs allocated to public warrants would be allocated to
permanent equity if the public warrants are classified as equity instruments
and would be immediately expensed if the public warrants are classified as
liabilities that are initially and subsequently measured at fair value, with
changes in fair value reported in earnings. For further discussion of the
allocation of costs, see Section 3.3.4.4 of Deloitte’s
Roadmap Distinguishing Liabilities From
Equity.
D.6.6.2 Issuance Costs Incurred in Conjunction With the Merger of a SPAC and Target
Certain costs that the target company incurs in conjunction with a merger
with a SPAC may represent direct and incremental costs (i.e., costs that
qualify for deferral as part of the reverse capitalization). To properly
account for them, the target company may need to allocate the eligible costs
to the respective instruments issued or assumed in the SPAC merger.
If the target company in the SPAC merger does not recognize any liabilities
that must be subsequently accounted for at fair value, with changes in fair
value reported in earnings, it can recognize all direct and incremental
costs in equity (i.e., APIC). However, the target company must take
additional considerations into account if it recognizes any
liability-classified instrument that is subsequently measured at fair value
through earnings because the costs related (or allocated) to such
instruments must be expensed as incurred.
When the target company issues, or assumes in the SPAC merger, any
liability-classified instruments that are subsequently accounted for at fair
value, the company should first evaluate whether any eligible costs are
directly related to a specific instrument. Such costs should be allocated to
that instrument and capitalized or expensed as appropriate (i.e., costs
allocated to an equity instrument are recognized in equity, and costs
allocated to a liability instrument that is subsequently reported at fair
value through earnings are expensed as incurred). Other direct and
incremental costs that are not directly related to a specific instrument
should be allocated by using a rational basis. The accounting for costs
incurred in a reverse capitalization involving a SPAC is not specifically
addressed in U.S. GAAP. However, we believe that there are two acceptable
views on how to allocate direct and incremental costs that are not directly
related to a specific instrument:
-
View A: Allocate costs to all instruments assumed or issued in the SPAC merger on a relative fair value basis — Under this approach, eligible costs would be allocated to all the SPAC shares, SPAC warrants, and earn-out arrangements involved in the merger. Costs allocated to liability-classified instruments that are subsequently measured at fair value through earnings (e.g., SPAC warrants and earn-out arrangements entered into with the SPAC sponsor10) must be expensed as incurred.
-
View B: Allocate costs only to the SPAC shares and any newly issued instruments in the SPAC merger on a relative fair value basis — Under this approach, eligible costs would not be allocated to assumed liabilities such as liability-classified SPAC warrants. Rather, eligible costs would only be allocated to the SPAC shares and any newly issued instruments, such as earn-out arrangements. Costs allocated to liability-classified instruments that are subsequently measured at fair value through earnings (e.g., earn-out arrangements with the SPAC sponsor11) must be expensed as incurred.
D.6.7 SPAC Backstop Arrangements
During the panel discussion on current OCA projects at the 2023 AICPA & CIMA
Conference on Current SEC and PCAOB Developments, SEC Associate Chief Accountant
Carlton Tartar noted that there are still many complexities related to
debt-versus-equity classification of financial instruments, particularly in SPAC
transactions even though the volume of such transactions has declined. He
further stated that SPACs have historically used various types of financings to
ensure that they have the necessary funds to close their proposed business
combinations once a target has been identified. He observed that, more recently,
there has been an uptick in the use of a financing vehicle commonly referred to
as a backstop arrangement. In such an arrangement, an issuer would prepay an
amount to a counterparty to purchase a stated (or maximum) number of shares that
the counterparty holds and vote in favor of the business combination, or merger.
The counterparty has the right to (1) deliver the shares to the issuer at a
later date for a stated amount per share or (2) retain the shares and return the
prepayment.
Mr. Tartar highlighted an example in which a registrant proposed initially
recognizing the prepayment as an asset under ASC 480 to reflect the up-front
cash payment made to the counterparty. The SEC staff ultimately objected to this
approach because it believes that the substance of the prepayment is more akin
to a subscription receivable for transactions related to an entity’s own shares.
Accordingly, the staff determined that it is appropriate to record the
prepayment amount in contra equity in the manner described in Regulation S-X,
Rule 5-02. The staff did not provide a view on the subsequent accounting for the
instrument.
Footnotes
1
Direct and incremental costs associated with the offering that are paid
to third parties should be allocated to the associated freestanding
financial instruments after the allocation of proceeds discussed here
(see Section D.6.6 for more information).
2
The classification of the public warrants and Class A shares is discussed
below. In the discussion of the allocation of proceeds, it is assumed
that the Class A shares are classified as equity instruments.
3
Class B shares are generally converted into Class A shares upon a merger
of the SPAC with a target. In some cases, the holders can elect to
convert the Class B shares into Class A shares before completion of a
business combination. However, such conversion generally does not change
the fact that the shares held by the sponsor and its affiliates do not
have any redemption rights or rights to participate in the distribution
of proceeds upon a liquidation of the SPAC.
4
Public warrants generally possess the characteristics of a derivative
instrument in ASC 815-10-15-83. However, the guidance in ASC 815-40 must
be applied regardless of whether such warrants have all of these
characteristics.
5
Public warrants may also contain a provision that allows the SPAC to
call them for $0.01 per warrant if the fair value of the Class A
shares exceeds $18 for a defined number of trading days. This
feature is only considered an exercise contingency because it does
not change the settlement terms.
6
Note that in this example, “Common Stock” refers to
the Class A shares of the SPAC. After a merger of the SPAC with a
target, common stock refers to either (1) the single class of common
shares of the combined entity or (2) the Class A common shares if
the combined entity has multiple classes of common shares.
7
It is also acceptable to classify the public warrants as liabilities
provided that the approach selected is applied consistently to all
instruments with such features.
8
In the example, the difference arises
because of the reference to Section [Z] of the warrant
agreement, which explains that public warrants are
subject to redemption (i.e., forced exercise) while
private placement warrants are not.
9
As discussed above, in this section, it is assumed
that the private placement warrants are not within the scope of ASC
718. If a private placement warrant is within the scope of ASC 718,
the classification would be determined on the basis of the
classification guidance in ASC 718. In these circumstances, if the
holder has no continuing service requirement after the SPAC merges
with a target and the transaction is accounted for as a reverse
recapitalization, the combined company should reassess the
accounting classification of the private placement warrant as of the
date of the merger with the SPAC in accordance with the
classification guidance in ASC 480-10 and ASC 815-40.
10
Earn-out arrangements entered into with all the target’s
shareholders on a pro rata basis are treated as
dividends. As a result, it is acceptable to recognize
the amounts allocated to these arrangements in
equity.
11
See footnote 10.